25 May 2013
Keywords: gsk, sells, part, its, quest, sake, 256m
Article | 30 March 2009
UK pharmaceutical giant GlaxoSmithKline says that it has sold 5,749,157 shares of common stock in Quest Diagnostics for a total of $256.0
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 March 2009
24 May 2013
© 2013 thepharmaletter.com